Screening of selected medicinal plants for urease inhibitory activity

Biology and Medicine

Volumn 2, Issue 4, 2010, Pages 64-69

  Ghous, Tahseen ^a   Akhtar, Kalsoom ^a   Nasim, Faiz Ul Hassan ^b   Choudhry, Muhammad Aziz ^a  

^a UNIVERSITY OF AZAD JAMMU AND KASHMIR   (Pakistan)

^b THE ISLAMIA UNIVERSITY OF BAHAWALPUR   (Pakistan)

Author keywords

Inhibition; Plant extract; Stomach infection; Urease

Indexed keywords

ACHILLEA; ACHILLEA MILLEFOLIUM; AZADIRACHTA INDICA; BRACTEATA; CUSCUTA; CUSCUTA REFLEXA; EUCALYPTUS; HELICOBACTER PYLORI; JUSTICIA; MALVA; MALVA PARVIFLORA; MELIA; MENTHA LONGIFOLIA; SOLANUM NIGRUM; TARAXACUM OFFICINALE;

EID: 84861963048     PISSN: None     EISSN: 09748369     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Amtul Z, Atta-ur-Rahman, Siddiqui RA, Choudhary MI, 2002. Chemistry and mechanism of urease inhibition. Current Medicinal Chemistry, 9(26): 1323-1348.
2. Andrews RK, Blakeley RL, Zerner B, 1984. Urea and urease. Inorganic Biochemistry, 6: 245-283.
3. Bae EA, Han MJ, Kim NJ, Kim DH, 1998. Anti H. pylori activity of herbal medicines. Biological & Pharmaceutical Bulletin, 21(9): 990-992.
4. Blaser MJ, 1990. Characteristics of a urease-negative H. pylori mutant strain. Revista Española de Enfermedades Digestivas, 78: 26-28.
5. Bode G, Mauch F, 1993. Medical microbiology and immunology, 182(5): 223-232.
6. Boer de WA, Guido N, Tytgat J, 2000. Treatment of H. pylori infection. British Medical Journal, 320: 31-34.
7. Cellin L, Campli ED, Masulli M, Bartolomeo SD, Allocati N, 1996. Inhibition of H. pylori by garlic extract (Allium sativum). FEMS Immunology and Medical Microbiology, 13: 277-279.
8. Clyne M, Dunn BE, Cohen H, Blaser MJ, 1993. Adherence of H. pylori to primary human gastrointestinal cells. Infection and Immunity, 61: 4051-4057.
9. Danesh J, Scholar R, Peto R, 1998. Risk factors for coronary heart disease and infection with H. pylori. British Medical Journal, 316: 1130-1132.
10. Dunn BE, Cohen H, Blaser MJ, 1997. H. pylori. Clinical Microbiology Reviews, 10: 720-741.
11. Ganga-Zandzou PS, Michaud L, Vincent P, Husson MO, Derambure NW, Delassalle EM, Turck D, Gottrand F, 1999. Natural outcome of H. pylori infection in asymptomatic children: A two year follow up study. Pediatrics, 104: 216-221.
12. Germanò P, Sanogo R, Guglielmo M, DePasquale R, Crisafi G, Bisignano G, 1998. Effects of Pteleopsis suberosa extracts on experimental gastric ulcers and H. pylori growth. Journal of Ethnopharmacology, 59 (3): 167-172.
13. Jodi A, Worrel PD, Steven C, Stoner PD, 1998. Eradication of H. pylori. Medical Update for Psychiatrists, 4(3): 99-104.
14. Kattak SG, Gilani SN, Ikram M, 1985. Anti-pyretic studies on some indigenous Pakistani medicinal plants. Journal of Ethnopharmacology, 14: 45-51.
15. Mai UE, Perez-Perez GI, Wahl LM, Wahl SM, Blaser MJ, Smith PD, 1991. Soluble surface proteins from H. pylori activate monocyte macrophages by lipopolysaccharide-independent mechanism. Journal of Clinical Investigation, 87(3): 894-900.
16. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC, 1994. Relation of H. pylori infection and coronary heart disease. British Heart Journal, 71: 37-439.
17. Montecucco C, Papini E, Bernard de M, Zoratti M, 1999. Molecular and cellular activities of H. pylori pathogenic factors. FEBS Letters, 452: 16-21.
18. Ohsaki A, Takashima J, Chiba N, Kawamura M, 1999. Microanalysis of a selective potent anti-H. pylori compound in a Brazilian medicinal plant, Myroxylon peruiferum and the activity of analogues. Bioorganic & Medicinal Chemistry Letters, 9(8): 1109-1112.
19. Parente F, Maconi G, Sangaletti O, Minguzzi M, Vago L, Rossi E, Bianchi Porro G, 1996. Prevalence of H. pylori infection and related gastroduodenal lesions in spouses of H. pylori positive patients with duodenal ulcer. Gut, 39: 629-633.
20. Segal ED, Shon J, Tompkins LS, 1992. Characterization of H. pylori urease mutants. Infection and Immunity, 60: 1883-1889.
21. Spengler G, Molnar A, Klausz G, Mandi Y, Kawase M, Motohashi N, Molnar J, 2004. Inhibitory action of a new proton pump inhibitor Trifluoromethyl ketone derivative against the mobility of clarithromycin susceptible, and resistant H. pylori. International Journal of Antimicrobial Agents, 23 (6): 631-633.
22. Suzuki M, Miura S, Suematsu M, Fukumura D, Kurose I, Suzuki H, Kai A, Kudoh Y, Ohashi M, Tsuchiya M, 1992. H. pylori associated ammonia production enhances neutrophil dependent gastric mucosal cell injury. American Journal of Physiology, 263: 719-725.
23. Torres J, Drumm B, 2000. A comprehensive review of the natural history of H. pylori infection in children. Archives of Medical Research, 31: 431-469.
24. Tougas G, Chen M, Hwang Pharm DP, Liu MM, Eggleston MMS, 1999. Prevalence and impact of upper gastrointestinal symptoms in the Canadian population findings from the digestion study. American Journal of Gastroenterology, 94(10): 2845-2854.
25. Wang YC, Huang TL, 2005. Screening of anti-H. pylori herbs deriving from Taiwanese folk medicinal plants. FEMS Immunology and Medical Microbiology, 43(2): 295-300.
26. Weatherburn MW, 1967. Phenol hypochlorite reaction for determination of ammonia. Analytical Chemistry, 39: 971-974.
27. Yesilada E, Gurbuz I, Shibata H, 1999. Screening of Turkish anti-ulcerogenic folk remedies for anti-H. pylori activity. Journal of Ethnopharmacology, 66: 289-293.